Suchergebnisse - "Hadaschik, Boris A"

PubPharm (11)

1

Re : Active Surveillance Plus Enzalutamide Monotherapy vs Active Surveillance Alone in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial

enthalten in: European urology | 2022

von Kesch, C. | Hadaschik, B.

2

Deep Prostate-specific Antigen Response following Addition of Apalutamide to Ongoing Androgen Deprivation Therapy and Long-term Clinical Benefit in SPARTAN

enthalten in: European urology | 2022

von Saad, F. | Small, E. | Feng, F. | +11

3

Apalutamide Compared with Darolutamide for the Treatment of Non-metastatic Castration-Resistant Prostate Cancer : Efficacy and Tolerability in a Matching-Adjusted Indirect Comparison

enthalten in: Advances in therapy | 2022

von Chowdhury, S. | Oudard, S. | Uemura, H. | +6

4

Superior early and long-term continence following early micturition on day 2 after robot-assisted radical prostatectomy : a randomized prospective trial

enthalten in: World journal of urology | 2021

von Harke, N. | Wagner, C. | Liakos, N. | +4

5

Apalutamide and Overall Survival in Prostate Cancer

enthalten in: European urology | 2021

von Smith, M. | Saad, F. | Chowdhury, S. | +15

CommentIn: Nat Rev Urol. 2020 Nov;17(11):602. - PMID 32948853

6

Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer : an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial

enthalten in: The Lancet. Oncology | 2018

von Saad, F. | Cella, D. | Basch, E. | +12

CommentIn: Lancet Oncol. 2018 Oct;19(10):1275-1276. - PMID 30213450

7

MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

enthalten in: The New England journal of medicine | 2018

von Kasivisvanathan, V. | Rannikko, A. | Borghi, M. | +135

CommentIn: Nat Rev Clin Oncol. 2018 Jun;15(6):345. - PMID 29643470

8

Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer

enthalten in: The New England journal of medicine | 2018

von Smith, M. | Saad, F. | Chowdhury, S. | +116

CommentIn: Urology. 2018 Jun;116:1-2. - PMID 29596865

9

The Clinical Impact of Additional Late PET/CT Imaging with 68Ga-PSMA-11 (HBED-CC) in the Diagnosis of Prostate Cancer

enthalten in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 2017

von Afshar-Oromieh, A. | Sattler, L. | Mier, W. | +5

10

Prospective randomized evaluation of risk-adapted prostate-specific antigen screening in young men : the PROBASE trial

enthalten in: European urology | 2013

von Arsov, C. | Becker, N. | Hadaschik, B. | +14